Intelligent Investor

Virtus Health Limited (ASX: VRT) - Announcements

Current share price for VRT : $8.100 0 (0%)

ASX company news and announcements for Virtus Health Limited (VRT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Virtus Health Limited (VRT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Virtus Health Limited (VRT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Virtus Health Limited (VRT)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Update on next steps in relation to BGH offer 9 Jun 2022 6:30PM $8.130 $8.100 $7.810 fallen by 0.37%
- Appendix 2A 8 Jun 2022 7:06PM n/a $8.100 $7.810 n/a
- Change in substantial holding from BGH 8 Jun 2022 9:29AM $8.170 $8.100 $7.810 fallen by 0.86%
- Supplementary Bidder's Statement 7 Jun 2022 9:57AM $8.150 $8.100 $7.810 fallen by 0.61%
- Change in substantial holding from BGH 7 Jun 2022 9:36AM $8.150 $8.100 $7.810 fallen by 0.61%
- Ceasing to be a substantial holder - CapVest 3 Jun 2022 6:17PM $8.150 $8.100 $7.810 fallen by 0.61%
- Third Supplementary Target's Statement (CapVest offer) 3 Jun 2022 6:01PM $8.150 $8.100 $7.810 fallen by 0.61%
- Joint Supplementary Statement (BGH) Letters to shareholders 3 Jun 2022 5:56PM $8.150 $8.100 $7.810 fallen by 0.61%
- Withdrawal of CapVest Takeover 3 Jun 2022 10:10AM $8.150 $8.100 $7.810 fallen by 0.61%
- Change in substantial holding from BGH 3 Jun 2022 9:29AM $8.150 $8.100 $7.810 fallen by 0.61%
- Change in substantial holding from BGH 2 Jun 2022 9:30AM $8.150 $8.100 $7.810 fallen by 0.61%
- 4th Supplementary Target's and Bidder's Statements BGH offer 1 Jun 2022 3:38PM $8.170 $8.100 $7.810 fallen by 0.86%
- Notice of Cancellation of EGM of 6 June 2022 1 Jun 2022 10:19AM $8.160 $8.100 $7.810 fallen by 0.74%
- Change in substantial holding from BGH 1 Jun 2022 9:30AM $8.110 $8.100 $7.810 fallen by 0.12%
- Extension of BGH Takeover Offer Period 31 May 2022 9:32AM $8.150 $8.100 $7.810 fallen by 0.61%
- Change in substantial holding from BGH 31 May 2022 9:28AM $8.150 $8.100 $7.810 fallen by 0.61%
- Virtus 3rd Supplementary Target's Statement (BGH) 30 May 2022 7:07PM $8.150 $8.100 $7.810 fallen by 0.61%
- Virtus 2nd Supplementary Target's Statement (CapVest offer) 30 May 2022 7:04PM $8.150 $8.100 $7.810 fallen by 0.61%
- Virtus agrees next steps with BGH re revised offer 30 May 2022 9:56AM $8.080 $8.100 $7.810 risen by 0.25%
- Change in substantial holding from BGH 30 May 2022 9:28AM $8.080 $8.100 $7.810 risen by 0.25%
- VRT Directors change recommendation for BGH takeover offer 27 May 2022 10:02AM $8.150 $8.100 $7.810 fallen by 0.61%
- Change in substantial holding - CapVest 27 May 2022 9:23AM $8.150 $8.100 $7.810 fallen by 0.61%
- Update on CapVest transaction and Revised BGH offer 26 May 2022 8:54AM $8.150 $8.100 $7.810 fallen by 0.61%
- Supplementary Bidder's Statement 25 May 2022 9:40AM $8.150 $8.100 $7.810 fallen by 0.61%
- Revised BGH Offer 25 May 2022 9:36AM $8.150 $8.100 $7.810 fallen by 0.61%

26 - 50 of 500 results

Page 2 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.